Inhaled insulin: concerns remain
- PMID: 16735346
- PMCID: PMC1471927
- DOI: 10.1136/bmj.332.7552.1273-e
Inhaled insulin: concerns remain
Comment on
-
Inhaled insulin.BMJ. 2006 May 6;332(7549):1043-4. doi: 10.1136/bmj.332.7549.1043. BMJ. 2006. PMID: 16675787 Free PMC article. No abstract available.
References
-
- Hsia CW, Raskin P. The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin. Am J Med 2005;118: 205-11. - PubMed
-
- Quattrin T, Belanger A, Bohannon NJV, Schwartz SL. Exubera Phase III Study Group. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes. Diabetes Care 2004;27: 2622-7. - PubMed
-
- Skyler JS, Weinstock RS, Raskin P, Yale JF, Barrett E, Gerich JE, et al. Exubera Phase III Study Group. Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects. Diabetes Care 2005;28: 1630-5. - PubMed
-
- Teeter JG, Becker R. The clinical relevance of inhaled insulin in the diabetic lung. Am J Med 2006;119: 184-90. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical